1. Home
  2. DMAC vs PWOD Comparison

DMAC vs PWOD Comparison

Compare DMAC & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • PWOD
  • Stock Information
  • Founded
  • DMAC 2000
  • PWOD 1934
  • Country
  • DMAC United States
  • PWOD United States
  • Employees
  • DMAC N/A
  • PWOD N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • PWOD Major Banks
  • Sector
  • DMAC Health Care
  • PWOD Finance
  • Exchange
  • DMAC Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • DMAC 190.2M
  • PWOD 179.7M
  • IPO Year
  • DMAC N/A
  • PWOD N/A
  • Fundamental
  • Price
  • DMAC $4.36
  • PWOD $24.49
  • Analyst Decision
  • DMAC Strong Buy
  • PWOD
  • Analyst Count
  • DMAC 2
  • PWOD 0
  • Target Price
  • DMAC $7.00
  • PWOD N/A
  • AVG Volume (30 Days)
  • DMAC 67.1K
  • PWOD 10.0K
  • Earning Date
  • DMAC 11-11-2024
  • PWOD 10-23-2024
  • Dividend Yield
  • DMAC N/A
  • PWOD 5.23%
  • EPS Growth
  • DMAC N/A
  • PWOD N/A
  • EPS
  • DMAC N/A
  • PWOD 2.31
  • Revenue
  • DMAC N/A
  • PWOD $64,822,000.00
  • Revenue This Year
  • DMAC N/A
  • PWOD N/A
  • Revenue Next Year
  • DMAC N/A
  • PWOD N/A
  • P/E Ratio
  • DMAC N/A
  • PWOD $10.59
  • Revenue Growth
  • DMAC N/A
  • PWOD N/A
  • 52 Week Low
  • DMAC $1.94
  • PWOD $17.01
  • 52 Week High
  • DMAC $4.95
  • PWOD $24.49
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 58.96
  • PWOD 67.69
  • Support Level
  • DMAC $4.11
  • PWOD $23.35
  • Resistance Level
  • DMAC $4.48
  • PWOD $24.15
  • Average True Range (ATR)
  • DMAC 0.20
  • PWOD 0.48
  • MACD
  • DMAC -0.00
  • PWOD 0.11
  • Stochastic Oscillator
  • DMAC 74.63
  • PWOD 100.00

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: